J Korean Diabetes.  2020 Mar;21(1):6-10. 10.4093/jkd.2020.21.1.6.

Management of Type 2 Diabetes Mellitus in Adolescents and Young Adults

• Lee KA

• KMID: 2506768
• DOI: http://doi.org/10.4093/jkd.2020.21.1.6

Abstract

Although type 1 diabetes remains more common among children and adolescents, the prevalence of obesity and type 2 diabetes among children, adolescents, and young adults is dramatically increasing. Young-onset type 2 diabetes exhibits a stronger family history, a greater association with obesity, early loss of insulin secretion capacity with insulin resistance, early onset and rapid progression of chronic complications, and frequent need for early introduction of insulin. Therefore, the management of type 2 diabetes in this age group is challenging and there are age-specific concerns. Young-onset type 2 diabetes affects more individuals of working age, increasing the adverse societal effects of the disease. This article describes the epidemiology, pathophysiology, diagnosis, and management of type 2 diabetes in adolescents and young adults.

Keyword

Adolescents; Diabetes mellitus, type 2; Young adult

Reference

1. Korean Diabetes Association. Diabetes fact sheet in Korea 2018. Seoul: Korean Diabetes Association;2018.

2. Korean Diabetes Association. Diabetes fact sheet in Korea 2015. Seoul: Korean Diabetes Association;2015.

3. Cho EH, Shin D, Cho KH, Hur J. Prevalences and management of diabetes and pre-diabetes among Korean teenagers and young adults: results from the Korea National Health and Nutrition Examination Survey 2005-2014. J Korean Med Sci. 2017; 32:1984–90.

4. Lascar N, Brown J, Pattison H, Barnett AH, Bailey CJ, Bellary S. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 2018; 6:69–80.

5. Copeland KC, Zeitler P, Geffner M, Guandalini C, Higgins J, Hirst K, Kaufman FR, Linder B, Marcovina S, McGuigan P, Pyle L, Tamborlane W, Willi S. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. J Clin Endocrinol Metab. 2011; 96:159–67.

6. TODAY Study Group. Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY. Diabetes Care. 2013; 36:1749–57.

7. Wilmot E, Idris I. Early onset type 2 diabetes: risk factors, clinical impact and management. Ther Adv Chronic Dis. 2014; 5:234–44.

8. Arslanian S, Bacha F, Grey M, Marcus MD, White NH, Zeitler P. Evaluation and management of youth-onset type 2 diabetes: a position statement by the American Diabetes Association. Diabetes Care. 2018; 41:2648–68.

9. American Diabetes Association. 13. Children and adolescents: standards of medical care in diabetes-2019. Diabetes Care. 2019; 42(Suppl 1):S148–64.

10. Korean Diabetes Association. Treatment guideline for diabetes. 6th ed.Seoul: Gold’ Planning and Development;2019. p. 154–6.

11. Marcus MD, Wilfley DE, El Ghormli L, Zeitler P, Linder B, Hirst K, levers-Landis CE, van Buren DJ, Walders-Abramson N. Weight change in the management of youth-onset type 2 diabetes: the TODAY clinical trial experience. Pediatr Obes. 2017; 12:337–45.

12. Berkowitz RI, Marcus MD, Anderson BJ, Delahanty L, Grover N, Kriska A, Laffel L, Syme A, Venditti E, Van Buren DJ, Wilfley DE, Yasuda P, Hirst K. Adherence to a lifestyle program for youth with type 2 diabetes and its association with treatment outcome in the TODAY clinical trial. Pediatr Diabetes. 2018; 19:191–8.

13. TODAY Study Group, Zeitler P, Hirst K, Pyle L, Linder B, Copeland K, Arslanian S, Cuttler L, Nathan DM, Tollefsen S, Wilfley D, Kaufman F. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012; 366:2247–56.

14. Wong J, Molyneaux L, Constantino M, Twigg SM, Yue DK. Timing is everything: age of onset influences long-term retinopathy risk in type 2 diabetes, independent of traditional risk factors. Diabetes Care. 2008; 31:1985–90.

15. Al-Saeed AH, Constantino MI, Molyneaux L, D’Souza M, Limacher-Gisler F, Luo C, Wu T, Twigg SM, Yue DK, Wong J. An inverse relationship between age of type 2 diabetes onset and complication risk and mortality: the impact of youth-onset type 2 diabetes. Diabetes Care. 2016; 39:823–9.

16. Dabelea D, Stafford JM, Mayer-Davis EJ, D’Agostino R Jr, Dolan L, Imperatore G, Linder B, Lawrence JM, Marcovina SM, Mottl AK, Black MH, Pop-Busui R, Saydah S, Hamman RF, Pihoker C. Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood. JAMA. 2017; 317:825–35.

17. Dart AB, Martens PJ, Rigatto C, Brownell MD, Dean HJ, Sellers EA. Earlier onset of complications in youth with type 2 diabetes. Diabetes Care. 2014; 37:436–43.

18. Zeitler P, Arslanian S, Fu J, Pinhas-Hamiel O, Reinehr T, Tandon N, Urakami T, Wong J, Maahs DM. ISPAD Clinical Practice Consensus Guidelines 2018: type 2 diabetes mellitus in youth. Pediatr Diabetes. 2018; 19(Suppl 27):28–46.

19. Anderson BJ, Edelstein S, Abramson NW, Katz LE, Yasuda PM, Lavietes SJ, Trief PM, Tollefsen SE, McKay SV, Kringas P, Casey TL, Marcus MD. Depressive symptoms and quality of life in adolescents with type 2 diabetes: baseline data from the TODAY study. Diabetes Care. 2011; 34:2205–7.

20. Lawrence JM1, Standiford DA, Loots B, Klingensmith GJ, Williams DE, Ruggiero A, Liese AD, Bell RA, Waitzfelder BE, McKeown RE. Prevalence and correlates of depressed mood among youth with diabetes: the SEARCH for Diabetes in Youth study. Pediatrics. 2006; 117:1348–58.

21. Korean Diabetes Association. The education guide for diabetes. 3rd ed.Seoul: Gold’ Planning and Development;2013. p. 215–23.